🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an efficacy and safety study of ertugliflozin in participants with ...
Status
Completed
Location
Multiple Locations
Start Date
2013-12-13
Trial ID
NCT02033889
There are no guidelines for the management of glucocorticoid- (henceforth s...
Status
Completed
Location
Washington University in St. Louis
Start Date
2013-09
Trial ID
NCT02012465
Treatments Being Tested
The purpose of this study is to compare two simple and safe emergency depar...
Status
Completed
Location
John H Stroger Hospital Of Cook County
Start Date
2004-09
Trial ID
NCT00732524
Treatments Being Tested
The purposes of this study are to determine the pharmacokinetics and pharma...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-06
Trial ID
NCT01374178
Premixed insulin-based therapy is a standard insulin treatment strategy in ...
Status
Completed
Location
Medical University Of Vienna, Department of Internal Medicine III
Start Date
2014-11
Trial ID
NCT02168491
Treatments Being Tested
Primary Objective: To demonstrate the superiority of the insulin glargine/...
Status
Completed
Location
Investigational Site Number 01
Start Date
2018-06-19
Trial ID
NCT03529123
This trial is conducted in Europe. The aim of this research is to assess th...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00313742
Treatments Being Tested
INHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2021-09-29
Trial ID
NCT04974528
Treatments Being Tested
Primary Objective: To investigate the efficacy(HbA1c) at 6 months after ad...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2013-12
Trial ID
NCT02027753
Treatments Being Tested
The main purpose of this study is to investigate the side effects related t...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Start Date
2017-03-06
Trial ID
NCT03025009
Treatments Being Tested